Stay updated with breaking news from Biolase Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Research analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a research report issued to clients and investors on Tuesday. The firm set a “sell” rating on the medical technology company’s stock. Separately, Benchmark reaffirmed a “speculative buy” rating and set a $0.40 target price on shares of BIOLASE […]
BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) was the target of a significant growth in short interest in the month of May. As of May 15th, there was short interest totalling 1,670,000 shares, a growth of 474.9% from the April 30th total of 290,500 shares. Currently, 5.2% of the company’s shares are sold short. Based […]
Benchmark reiterated their speculative buy rating on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a report released on Tuesday, Benzinga reports. Benchmark currently has a $0.40 target price on the medical technology company’s stock. Separately, StockNews.com started coverage on BIOLASE in a research note on Sunday, May 12th. They issued a sell rating for […]
According to Market.Us, the global dental lasers market was valued at USD 292.5 million in 2022, and it is projected to reach approximately USD 550.5 million by 2032. The market is anticipated to experience a compound annual growth rate (CAGR) of 6.7% from 2023 to 2032, marking the highest growth rate within this pe...
StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL – Get Free Report) in a note issued to investors on Tuesday. The firm set a “sell” rating on the medical technology company’s stock. BIOLASE Price Performance Shares of BIOLASE stock opened at $0.18 on Tuesday. The company has a current ratio of 1.26, a quick ratio […]